复锐医疗科技有限公司（股票代码：01696）于2026年11月5日发布公告，披露当日通过香港联合交易所场内回购合计16000股普通股，占此前公司已发行股本（不包括库存股份）的约0.003%。本次回购价格区间介乎每股1.81港元至1.835港元，合计支付约28990港元（约2.90万港元）。
根据公告，本次回购完成后，公司已发行股份（不包括库存股份数）减少至467443892股，而库存股份增加至899200股，合计已发行股本仍为468343092股。此次回购依据2026年6月24日股东大会上授予的股份回购授权进行，该授权允许公司回购不超过46834309股股份。截至目前，公司已在公开市场及其他证券交易所累计根据该授权回购899200股股份，占授权通过时公司已发行股本（不包括库存股份）的约0.192%。
公司于公告中确认，本次回购操作严格遵守香港联交所证券上市规则及相关法律法规。公告由公司秘书方前厉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.